TRIAMINIC COLD & ALLERGY OTC
Generic Name and Formulations:
Chlorpheniramine maleate 1mg, phenylephrine HCl 2.5mg; per 5mL; liq; alcohol-free; orange-flavored; contains sodium 3mg/5mL.
Novartis Consumer Health
Indications for TRIAMINIC COLD & ALLERGY:
Rhinorrhea, congestion, allergy symptoms.
<4yrs: do not use. 4–6yrs: individualize. 6–12yrs: 10mL. Repeat every 4 hours as needed; max 6 doses/24 hours.
Children <4yrs old. During or within 14 days of MAOIs. For use as a sedative hypnotic.
Hypertension. Cardiovascular disease. Thyroid disease. Diabetes. Glaucoma. Asthma. Lower respiratory disorders.
Antihistamine + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, dizziness, nervousness, insomnia, excitability in children.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age